Amalgamated Bank’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,690
Closed -$2K 3112
2025
Q1
$2K Hold
1,690
﹤0.01% 2862
2024
Q4
$3K Hold
1,690
﹤0.01% 2866
2024
Q3
$6K Hold
1,690
﹤0.01% 2717
2024
Q2
$6K Buy
+1,690
New +$7.11K ﹤0.01% 2712
2022
Q2
Sell
-1,543
Closed -$6K 3166
2022
Q1
$6K Buy
+1,543
New +$11.3K ﹤0.01% 3018

Other funds holding PYXS

Amalgamated Bank's PYXS Position: Q2 2025 in Review

Amalgamated Bank sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 1,690 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in PYXS in Q1 2022 and held it in 5 quarters. The position peaked at $6K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • Amalgamated Bank reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,690 Pyxis Oncology shares in Q2 2025, an estimated $2K.
  • Amalgamated Bank first reported a position in Pyxis Oncology in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Pyxis Oncology position peaked at $6K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.